Sotatercept in pulmonary arterial hypertension: revolution, risk and the road ahead. [PDF]
Hoeper MM.
europepmc +1 more source
Sotatercept in Pulmonary Arterial Hypertension: Molecular Mechanisms, Clinical Evidence, and Emerging Role in Reverse Remodelling. [PDF]
Tilea I +4 more
europepmc +1 more source
Emerging Role of Myostatin Inhibitors in the Management of Glucagon-Like Peptide-1-Associated Sarcopenia and Metabolic Disorders. [PDF]
Baik J, Lee YS.
europepmc +1 more source
Muscle-derived myostatin is a major endocrine driver of follicle-stimulating hormone synthesis. [PDF]
Ongaro L +21 more
europepmc +1 more source
Ineffectiveness of Sotatercept Therapy in a Patient With Heritable Pulmonary Arterial Hypertension Associated With a Previously Unreported Missense Variant in GDF2, the Gene for Bone Morphogenic Protein-9. [PDF]
Langleben D +5 more
europepmc +1 more source
Activin A/Follistatin Axis in Airway Diseases and its Association With Recurrent Exacerbations. [PDF]
Chatziantoniou A +9 more
europepmc +1 more source
Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: Current Therapeutic Strategies and Future Prospects. [PDF]
Yokoyama YM +10 more
europepmc +1 more source
Single‑dose levamisole at breeding alters early pregnancy immune-endocrine profiles without affecting fertility in ewes. [PDF]
Rişvanlı A +10 more
europepmc +1 more source

